ACON PHARMACEUTICALS INC

Address: 2557 Route 130 S, Suite 3, Cranbury, New Jersey, 08512-3509

Phone: (856) 347-7699

Contact Person: XUDONG YUAN

Legal Structure: Corporation

Year Established: 2020

Business Type: Manufacturing (10 %), Research and Development (70 %), Service (20 %)

Sales/Service Area: Belgium; Brazil; Canada; Sri Lanka; China; Cayman Islands; Colombia; Costa Rica; Cyprus; Denmark; Egypt; Ireland; Czech Republic; Finland; France; Germany; Greece; Hong Kong; Croatia; Hungary; Iceland; India; Israel; Italy; Japan; Korea, Republic of; Lithuania; Slovakia; Luxembourg; Macau; Monaco; Morocco; Malta; Maldives; Mexico; Malaysia; Netherlands; Norway; Netherlands Antilles; New Zealand; Paraguay; Peru; Poland; Panama; Portugal; Philippines; Saudi Arabia; South Africa; Slovenia; Singapore; Spain; Sweden; Switzerland; Trinidad and Tobago; Thailand; Turkey; Taiwan; United Kingdom; Uruguay; Venezuela; British Virgin Islands

Principals: 1. Xudong Yuan, CEO

Ownership: Asian Pacific American, Other Minority Owned, Self-Certified Small Disadvantaged Business

Products & Services

Acon Pharmaceuticals Inc. (Acon Pharma) is a specialty pharmaceutical company and focuses on ANDA and 505(b)(2) NDA drug product development with its captive drug delivery system technology platforms. Acon Pharma is a privately held corporation located in Princeton, New Jersey, USA. As a dynamic pharmaceutical company in a vibrant life science research region, Acon Pharma leverages the expertise and experience of highly skilled, multi-disciplinary workforce to accelerate the product development of complex drug delivery systems. The Company¡¯s key managers were primarily educated in US with advanced degrees and trained in the pharmaceutical industry for many years, and have possessed deep professional knowledge, technical know-how, and extensive experiences in pharmaceutical product development.

Our expertise covers drug development and delivery of poorly soluble small molecule drugs, siRNA, oligonucleotides, peptides, protein, and plasmid DNA. Our formulation technology platforms include nanoparticles, microspheres / microparticles, nanocrystals, liposome, implant, long-acting injectable, oral fast dissolving film (ODF), transdermal patches, resinate / polistirex suspension, nasal spray, topical cream, gel, ointment, nanoemulsion, microemulsion, self-emulsifying system, tablets, capsules, inhalers, controlled release, modified release, and delayed release. Please talk to us today for co-development opportunities.

Keywords

Pharmaceuticals R&d Services

NAICS Code(s)

541690: Other Scientific and Technical Consulting Services

If you notice any discrepancies in your company profile, or wish to request updates or removals, please contact us to ensure your information is accurate and up-to-date.